These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 34883342)

  • 1. Fluvastatin enhances IL-33-mediated mast cell IL-6 and TNF production.
    Taruselli MT; Kolawole EM; Qayum AA; Haque TT; Caslin HL; Abebayehu D; Kee SA; Dailey JM; Jackson KG; Burchett JR; Spence AJ; Pondicherry N; Barnstein BO; Gomez G; Straus DB; Ryan JJ
    Cell Immunol; 2022 Jan; 371():104457. PubMed ID: 34883342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluvastatin Suppresses Mast Cell and Basophil IgE Responses: Genotype-Dependent Effects.
    Kolawole EM; McLeod JJ; Ndaw V; Abebayehu D; Barnstein BO; Faber T; Spence AJ; Taruselli M; Paranjape A; Haque TT; Qayum AA; Kazmi QA; Wijesinghe DS; Sturgill JL; Chalfant CE; Straus DB; Oskeritzian CA; Ryan JJ
    J Immunol; 2016 Feb; 196(4):1461-70. PubMed ID: 26773154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluvastatin Induces Apoptosis in Primary and Transformed Mast Cells.
    Paez PA; Kolawole M; Taruselli MT; Ajith S; Dailey JM; Kee SA; Haque TT; Barnstein BO; McLeod JJA; Caslin HL; Kiwanuka KN; Fukuoka Y; Le QT; Schwartz LB; Straus DB; Gewirtz DA; Martin RK; Ryan JJ
    J Pharmacol Exp Ther; 2020 Jul; 374(1):104-112. PubMed ID: 32434944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential effect of LFA703, pravastatin, and fluvastatin on production of IL-18 and expression of ICAM-1 and CD40 in human monocytes.
    Takahashi HK; Mori S; Iwagaki H; Yoshino T; Tanaka N; Weitz-Schmidt G; Nishibori M
    J Leukoc Biol; 2005 Mar; 77(3):400-7. PubMed ID: 15618295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Didox (3,4-dihydroxybenzohydroxamic acid) suppresses IgE-mediated mast cell activation through attenuation of NFκB and AP-1 transcription.
    McLeod JJA; Caslin HL; Spence AJ; Kolawole EM; Qayum AA; Paranjape A; Taruselli M; Haque TT; Kiwanuka KN; Elford HL; Ryan JJ
    Cell Immunol; 2017 Dec; 322():41-48. PubMed ID: 28964543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibiting Isoprenylation Suppresses FcεRI-Mediated Mast Cell Function and Allergic Inflammation.
    Dailey JM; Kee SA; Tharakan A; Kazi A; Burchett JR; Kolawole EM; Boyd Ballance W; Kotha A; Le QT; Schwartz LB; Straus DB; Martin RK; Sebti SM; Ryan JJ
    J Immunol; 2023 Aug; 211(4):527-538. PubMed ID: 37449905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Berberine suppresses IL-33-induced inflammatory responses in mast cells by inactivating NF-κB and p38 signaling.
    Li W; Yin N; Tao W; Wang Q; Fan H; Wang Z
    Int Immunopharmacol; 2019 Jan; 66():82-90. PubMed ID: 30445310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calcineurin-Rcan1 interaction contributes to stem cell factor-mediated mast cell activation.
    Wu Z; Li Y; MacNeil AJ; Junkins RD; Berman JN; Lin TJ
    J Immunol; 2013 Dec; 191(12):5885-94. PubMed ID: 24218457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TGF-β1 Suppresses IL-33-Induced Mast Cell Function.
    Ndaw VS; Abebayehu D; Spence AJ; Paez PA; Kolawole EM; Taruselli MT; Caslin HL; Chumanevich AP; Paranjape A; Baker B; Barnstein BO; Haque TT; Kiwanuka KN; Oskeritzian CA; Ryan JJ
    J Immunol; 2017 Aug; 199(3):866-873. PubMed ID: 28637902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of statins on the mevalonic acid pathway in recombinant yeast strains expressing human HMG-CoA reductase.
    Maciejak A; Leszczynska A; Warchol I; Gora M; Kaminska J; Plochocka D; Wysocka-Kapcinska M; Tulacz D; Siedlecka J; Swiezewska E; Sojka M; Danikiewicz W; Odolczyk N; Szkopinska A; Sygitowicz G; Burzynska B
    BMC Biotechnol; 2013 Aug; 13():68. PubMed ID: 24128347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HMG-CoA reductase inhibitor simvastatin inhibits proinflammatory cytokine production from murine mast cells.
    Kagami S; Kanari H; Suto A; Fujiwara M; Ikeda K; Hirose K; Watanabe N; Iwamoto I; Nakajima H
    Int Arch Allergy Immunol; 2008; 146 Suppl 1():61-6. PubMed ID: 18504409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Statins prevent endothelial cell activation induced by antiphospholipid (anti-beta2-glycoprotein I) antibodies: effect on the proadhesive and proinflammatory phenotype.
    Meroni PL; Raschi E; Testoni C; Tincani A; Balestrieri G; Molteni R; Khamashta MA; Tremoli E; Camera M
    Arthritis Rheum; 2001 Dec; 44(12):2870-8. PubMed ID: 11762948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypothesis: the antitumor activities of statins may be mediated by IL-18.
    Takahashi HK; Weitz-Schmidt G; Iwagaki H; Yoshino T; Tanaka N; Nishibori M
    J Leukoc Biol; 2006 Aug; 80(2):215-6. PubMed ID: 16735695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HMG-CoA reductase inhibitor fluvastatin prevents angiotensin II-induced cardiac hypertrophy via Rho kinase and inhibition of cyclin D1.
    Morikawa-Futamatsu K; Adachi S; Maejima Y; Tamamori-Adachi M; Suzuki J; Kitajima S; Ito H; Isobe M
    Life Sci; 2006 Aug; 79(14):1380-90. PubMed ID: 16712874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin (IL)-10 inhibits long-term IL-6 production but not preformed mediator release from rat peritoneal mast cells.
    Marshall JS; Leal-Berumen I; Nielsen L; Glibetic M; Jordana M
    J Clin Invest; 1996 Feb; 97(4):1122-8. PubMed ID: 8613537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An actionable sterol-regulated feedback loop modulates statin sensitivity in prostate cancer.
    Longo J; Mullen PJ; Yu R; van Leeuwen JE; Masoomian M; Woon DTS; Wang Y; Chen EX; Hamilton RJ; Sweet JM; van der Kwast TH; Fleshner NE; Penn LZ
    Mol Metab; 2019 Jul; 25():119-130. PubMed ID: 31023626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism of TNFalpha-induced IL-1alpha, IL-1beta and IL-6 expression in human cardiac fibroblasts: effects of statins and thiazolidinediones.
    Turner NA; Mughal RS; Warburton P; O'Regan DJ; Ball SG; Porter KE
    Cardiovasc Res; 2007 Oct; 76(1):81-90. PubMed ID: 17612514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NF-kappa B and TNF-alpha: a positive autocrine loop in human lung mast cells?
    Coward WR; Okayama Y; Sagara H; Wilson SJ; Holgate ST; Church MK
    J Immunol; 2002 Nov; 169(9):5287-93. PubMed ID: 12391248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential release of mast cell interleukin-6 via c-kit.
    Gagari E; Tsai M; Lantz CS; Fox LG; Galli SJ
    Blood; 1997 Apr; 89(8):2654-63. PubMed ID: 9108382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Statins prevent NF-kappaB transactivation independently of the IKK-pathway in human endothelial cells.
    Hölschermann H; Schuster D; Parviz B; Haberbosch W; Tillmanns H; Muth H
    Atherosclerosis; 2006 Apr; 185(2):240-5. PubMed ID: 16051251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.